1. Home
  2. HYPD

Stocks

NYSE

Hyperion DeFi Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.

Founded: 2014 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 73.3M IPO Year: 2018
Target Price: N/A AVG Volume (30 days): 6.5M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -34.33 EPS Growth: N/A
52 Week Low/High: $0.85 - $124.80 Next Earning Date: 08-11-2025
Revenue: $67,063 Revenue Growth: 663.82%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: